Share based payments - Rollforward (Details) |
12 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Oct. 01, 2024
shares
|
May 16, 2024
shares
|
Dec. 31, 2024
EquityInstruments
€ / shares
|
Dec. 31, 2023
EquityInstruments
€ / shares
|
Dec. 31, 2022
EquityInstruments
€ / shares
|
Dec. 31, 2021
EquityInstruments
€ / shares
|
|
| Share based payments | ||||||
| Outstanding at the beginning of the year | EquityInstruments | 11,472,520 | 10,816,856 | 8,579,837 | |||
| Granted during the year | 41,000 | 1,340,000 | 1,381,000 | 1,538,400 | 3,127,239 | |
| Forfeited during the year | EquityInstruments | (547,911) | (544,676) | (607,430) | |||
| Exercised during year | EquityInstruments | (61,560) | (282,790) | ||||
| Expired during the year | EquityInstruments | (394,500) | (276,500) | ||||
| Outstanding at the end of the year | EquityInstruments | 11,911,109 | 11,472,520 | 10,816,856 | |||
| Exercisable | EquityInstruments | 5,182,941 | 5,836,538 | 2,574,218 | 1,751,013 | ||
| Weighted average exercise price at beginning of the year | € 77.93 | € 83.12 | € 92.69 | |||
| Granted during the period | 26.87 | 35.53 | 54.71 | |||
| Forfeited during the year | 72.66 | 80.31 | 100 | |||
| Exercised during the period | 0 | 28.75 | 23.68 | |||
| Expired during the year | 46.1 | 49 | ||||
| Weighted average exercise price at end of the year | 73.19 | 77.93 | 83.12 | |||
| Exercisable | € 107.03 | € 101.93 | € 70.26 | € 56.64 | ||